- Home
- OSCR vs MLTX Comparison
OSCR vs MLTX Comparison
Compare OSCR & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSCR
- MLTX
- Stock Information
- Founded
- OSCR 2012
- MLTX 2021
- Country
- OSCR United States
- MLTX Switzerland
- Employees
- OSCR N/A
- MLTX N/A
- Industry
- OSCR Accident &Health Insurance
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- OSCR Finance
- MLTX Health Care
- Exchange
- OSCR Nasdaq
- MLTX Nasdaq
- Market Cap
- OSCR 3.2B
- MLTX 2.8B
- IPO Year
- OSCR 2021
- MLTX N/A
- Fundamental
- Price
- OSCR $13.58
- MLTX $52.92
- Analyst Decision
- OSCR Sell
- MLTX Strong Buy
- Analyst Count
- OSCR 7
- MLTX 7
- Target Price
- OSCR $12.79
- MLTX $73.33
- AVG Volume (30 Days)
- OSCR 37.9M
- MLTX 557.2K
- Earning Date
- OSCR 08-06-2025
- MLTX 08-11-2025
- Dividend Yield
- OSCR N/A
- MLTX N/A
- EPS Growth
- OSCR N/A
- MLTX N/A
- EPS
- OSCR 0.46
- MLTX N/A
- Revenue
- OSCR $10,081,522,000.00
- MLTX N/A
- Revenue This Year
- OSCR $31.12
- MLTX N/A
- Revenue Next Year
- OSCR N/A
- MLTX N/A
- P/E Ratio
- OSCR $29.40
- MLTX N/A
- Revenue Growth
- OSCR 54.26
- MLTX N/A
- 52 Week Low
- OSCR $11.20
- MLTX $31.42
- 52 Week High
- OSCR $23.79
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- OSCR 41.05
- MLTX 57.74
- Support Level
- OSCR $13.75
- MLTX $46.12
- Resistance Level
- OSCR $14.62
- MLTX $55.91
- Average True Range (ATR)
- OSCR 1.09
- MLTX 2.45
- MACD
- OSCR -0.09
- MLTX -0.46
- Stochastic Oscillator
- OSCR 23.37
- MLTX 60.02
About OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.